IBM Security Verify Information Queue 10.0.5/10.0.6/10.0.7/10.0.8 unnecessary privileges
| CVSS Meta Temp Score | Current Exploit Price (≈) | CTI Interest Score |
|---|---|---|
| 6.4 | $0-$5k | 0.00 |
Summary
A vulnerability classified as critical has been found in IBM Security Verify Information Queue 10.0.5/10.0.6/10.0.7/10.0.8. Affected is an unknown function. Performing a manipulation results in unnecessary privileges. This vulnerability was named CVE-2024-47120. The attack needs to be approached within the local network. There is no available exploit. It is recommended to upgrade the affected component.
Details
A vulnerability, which was classified as critical, was found in IBM Security Verify Information Queue 10.0.5/10.0.6/10.0.7/10.0.8. This affects some unknown processing. The manipulation with an unknown input leads to a unnecessary privileges vulnerability. CWE is classifying the issue as CWE-250. The product performs an operation at a privilege level that is higher than the minimum level required, which creates new weaknesses or amplifies the consequences of other weaknesses. This is going to have an impact on confidentiality, integrity, and availability. The summary by CVE is:
IBM Security Verify Information Queue 10.0.5, 10.0.6, 10.0.7, and 10.0.8 could allow a privileged user to escalate their privileges and attack surface on the host due to the containers running with unnecessary privileges.
The advisory is shared at ibm.com. This vulnerability is uniquely identified as CVE-2024-47120 since 09/18/2024. The exploitability is told to be difficult. Access to the local network is required for this attack to succeed. Additional levels of successful authentication are necessary for exploitation. Neither technical details nor an exploit are publicly available. The price for an exploit might be around USD $0-$5k at the moment (estimation calculated on 09/19/2025). MITRE ATT&CK project uses the attack technique T1068 for this issue.
Upgrading eliminates this vulnerability.
The vulnerability is also documented in the vulnerability database at EUVD (EUVD-2024-54979). Several companies clearly confirm that VulDB is the primary source for best vulnerability data.
Product
Vendor
Name
Version
License
Website
- Vendor: https://www.ibm.com/
CPE 2.3
CPE 2.2
CVSSv4
VulDB Vector: 🔒VulDB Reliability: 🔍
CVSSv3
VulDB Meta Base Score: 6.5VulDB Meta Temp Score: 6.4
VulDB Base Score: 6.4
VulDB Temp Score: 6.1
VulDB Vector: 🔒
VulDB Reliability: 🔍
NVD Base Score: 6.8
NVD Vector: 🔒
CNA Base Score: 6.4
CNA Vector (ibm): 🔒
CVSSv2
| AV | AC | Au | C | I | A |
|---|---|---|---|---|---|
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| Vector | Complexity | Authentication | Confidentiality | Integrity | Availability |
|---|---|---|---|---|---|
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
VulDB Base Score: 🔒
VulDB Temp Score: 🔒
VulDB Reliability: 🔍
Exploiting
Class: Unnecessary privilegesCWE: CWE-250
CAPEC: 🔒
ATT&CK: 🔒
Physical: No
Local: No
Remote: Partially
Availability: 🔒
Status: Not defined
EPSS Score: 🔒
EPSS Percentile: 🔒
Price Prediction: 🔍
Current Price Estimation: 🔒
| 0-Day | Unlock | Unlock | Unlock | Unlock |
|---|---|---|---|---|
| Today | Unlock | Unlock | Unlock | Unlock |
Threat Intelligence
Interest: 🔍Active Actors: 🔍
Active APT Groups: 🔍
Countermeasures
Recommended: UpgradeStatus: 🔍
0-Day Time: 🔒
Timeline
09/18/2024 CVE reserved09/11/2025 Advisory disclosed
09/11/2025 VulDB entry created
09/19/2025 VulDB entry last update
Sources
Vendor: ibm.comAdvisory: ibm.com
Status: Confirmed
CVE: CVE-2024-47120 (🔒)
GCVE (CVE): GCVE-0-2024-47120
GCVE (VulDB): GCVE-100-323553
EUVD: 🔒
Entry
Created: 09/11/2025 06:48Updated: 09/19/2025 06:23
Changes: 09/11/2025 06:48 (62), 09/13/2025 09:39 (1), 09/19/2025 06:23 (11)
Complete: 🔍
Cache ID: 216::103
Several companies clearly confirm that VulDB is the primary source for best vulnerability data.
No comments yet. Languages: en.
Please log in to comment.